X @Bloomberg
Bloomberg·2025-09-05 17:44Market Dynamics - Shares of Eli Lilly and Novo Nordisk experienced a decline [1] - US regulators established a "green list" of foreign manufacturers producing raw materials for GLP-1 drugs [1] Regulatory Landscape - The "green list" allows compounding pharmacies to create copies of blockbuster GLP-1 drugs [1]